ESMCOTCElectromedical & Electrotherapeutic ApparatusUS GAAP · USD

Escalon Medical Corp

Escalon Medical Corp. develops, manufactures, markets, and distributes ophthalmic medical devices and related products for eye-care procedures and diagnostics. Its portfolio includes ultrasound systems for biometric and diagnostic use, disposable surgical packs for vitreoretinal surgery, and the AXIS image management system for ophthalmic imaging workflows.

Kysy yhtiöstä
Liikevaihto12,7milj. USD
+5,7 %v/v
Liikevoitto (EBIT)0,0milj. USD
−66,0 %v/v
EBIT-marginaali0,4%
−0,8 %-yks.v/v
Nettotulos4,0milj. USD
+3 702,5 %v/v
Vapaa kassavirta−0,4milj. USD
−208,0 %v/v

Tilikausi 2026 · muutos edellisvuodesta

Kehitys 2021–2026

−5051015milj. USD2021: 10 milj. USD2021: EBIT −0,03 milj. USD20212022: 11 milj. USD2022: EBIT −0,47 milj. USD20222023: 12 milj. USD2023: EBIT 0,48 milj. USD20232024: 12 milj. USD2024: EBIT −0,10 milj. USD20242025: 12 milj. USD2025: EBIT 0,13 milj. USD20252026: 13 milj. USD2026: EBIT 0,05 milj. USD2026130,05
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: Escalon Medical Corp

Liiketoiminta

Osuus liikevaihdosta
Ophthalmic ultrasound systems45 %

A-Scan and B-Scan ultrasound devices and related software used for eye diagnostics and biometric measurements.

Ophthalmic surgical disposables35 %

Disposable surgical packs used in vitreoretinal surgery, including silicone oil handling packs.

Image management software10 %

AXIS Image Management system for storing and accessing ophthalmic diagnostic images through a web browser.

Service and support10 %

Repairs, warranties, and remote support for ultrasound, imaging, and surgical products.

Tuotteet

Raportoitu · osuus liikevaihdosta
94,9%FY2026100 %
  • Products94,9 %
  • Services5,1 %

Lähde: 10-K FY2026, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

Escalon sells primarily to medical institutions and eye-care providers that need diagnostic equipment, surgical consumables, and image management tools for ophthalmology workflows. Its customer base is served through independent sales representatives, distributors, and direct sales employees, which suggests a mix of hospital, clinic, and specialty practice end users. The company also supports installed customers with repair and service, which helps retain recurring relationships after the initial sale.

Ophthalmic hospitals and clinics

Buy ultrasound systems and image management tools to diagnose and monitor eye conditions.

Vitreoretinal surgeons

Buy disposable surgical packs and silicone oil handling packs for procedure-specific use.

Distributors and independent reps

Place products into local healthcare markets and expand reach without a large direct field force.

Existing installed-base customers

Purchase repairs, service, and replacement support for previously installed systems.

Strategia

Escalon’s strategy centers on refreshing ophthalmic products, supporting its installed base, and using regulatory clearances such as FDA registration and CE Mark to sell into more markets. The company also appears focused on maintaining a broad product mix across ultrasound, surgical disposables, and imaging software to reduce reliance on any single product line.

Product development and enhancementLyhyt aikaväli

R&D is tied to new and improved ophthalmic products that can drive adoption and offset mature product pressure.

International market accessKeskipitkä aikaväli

CE Mark and other clearances allow the company to sell beyond the U.S. and diversify demand.

Operational support and service retentionKeskipitkä aikaväli

Repairs, warranties, and remote support help preserve installed-base relationships and recurring revenue.

Maantiede

Escalon sells throughout the United States and internationally, with 56.0% of fiscal 2025 revenue generated domestically and 44.0% from foreign markets. The company manufactures and assembles ophthalmic surgical products in New Berlin, Wisconsin, and designs, assembles, and services ultrasound products in Lake Success, New York, so its operating footprint is concentrated in the U.S. while sales are globally distributed.

Riskit

Escalon faces meaningful execution and balance-sheet risk because it has a history of operating losses and management has disclosed substantial doubt about going concern. Its business is also exposed to regulatory, product liability, cybersecurity, and supply-chain risks, all of which can disrupt sales or raise costs in a small medical-device platform. Dependence on a few customers and suppliers adds concentration risk to an already narrow product base.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Going concern and liquidity pressure1Regulatory approval and compliance2Product liability3Customer and supplier concentration4Cybersecurity and data privacy5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Going concern and liquidity pressureVaikutus: KriittinenTodennäköisyys: Korkea

    The company has a history of operating losses and disclosed substantial doubt about continuing as a going concern.

    Kohdistuu: Cash to current liabilities and ability to raise capital

  2. Regulatory approval and complianceVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Medical devices require FDA and foreign clearances, and changes in rules can delay launches or restrict sales.

    KohdistuuFDACE MarkForeign regulatory approvals
  3. Product liabilityVaikutus: KorkeaTodennäköisyys: Matala

    Surgical and diagnostic products can create claims if defects or performance issues occur.

    Kohdistuu: Ophthalmic surgical packs and ultrasound systems

  4. Customer and supplier concentrationVaikutus: KorkeaTodennäköisyys: Matala

    A small number of customers and suppliers can materially affect sales, receivables, and production continuity.

    Kohdistuu: Top customer and key component vendors

  5. Cybersecurity and data privacyVaikutus: KeskitasoTodennäköisyys: Matala

    The company uses internet-based systems and stores confidential customer and employee data.

    Kohdistuu: AXIS image management and internal IT systems

Kysy Clarifolta: Escalon Medical Corp

Kirjanpito

Harkinnanvaraiset erät
Revenue mix and timing

Product revenue and service-plan revenue move differently and can change reported margins.

Vaikutus: Affects quarterly comparability and gross margin

Going concern and liquidity estimates

Management must assess whether cash resources and future operations support continued operations.

Vaikutus: Can influence disclosures and valuation assumptions

Allowance for doubtful accounts

Customer concentration and dispersed international sales require judgment on collectability.

Vaikutus: Affects net revenue and working capital

Inventory and warranty-related estimates

Medical-device products require estimates for obsolescence, returns, and warranty obligations.

Vaikutus: Affects cost of revenue and liabilities

Lease accounting

The company operates from leased facilities in New Berlin and Lake Success.

Vaikutus: Affects balance sheet assets and liabilities

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Alcon Inc

ALC · Ophthalmic Goods

RetinalGenix Technologies Inc.

RTGN · Surgical & Medical Instruments & Apparatus

LENSAR, Inc.

LNSR · Surgical & Medical Instruments & Apparatus

Ocular Therapeutix, Inc

OCUL · Pharmaceutical Preparations

OSI Systems, Inc

OSIS · Semiconductors & Related Devices

STAAR Surgical Company

STAA · Ophthalmic Goods

Päivitetty: 24.9.2026